NCT03719300: A reported trial by Anchiano Therapeutics Israel Ltd.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03719300 |
|---|---|
| Title | A Phase 2 Study of BC-819 in Patients With Non-Muscle Invasive Bladder Cancer Whose Disease is Unresponsive to Bacillus Calmette-Guerin |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 20, 2019 |
| Completion date | Nov. 18, 2019 |
| Required reporting date | Nov. 17, 2020, midnight |
| Actual reporting date | June 19, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |